Review article · 2024 · Open access

Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group

Hannah W. Song, Jennifer N. Solomon, Fernanda Masri, Amanda A. Mack, Nisha Durand, Emmanuelle Cameau, Noushin Dianat, Arwen L. Hunter, Steve Oh, Brianna Schoen, Matthew Marsh, Christopher A. Bravery and 5 more

Cytotherapy, 26(11), 1275–1284 · Published 1 June 2024 · DOI 10.1016/j.jcyt.2024.05.024

Open PDFView at the publisherCite this paper

In brief

“Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group” is a 2024 review article by Hannah W. Song and 16 co-authors, published in Cytotherapy. OpenAlex counts 14 citations as of 21 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
14
Most cited in
2026 (8)
Field-weighted impact
0.46
References
60
Authors
17

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Song, H. W., Solomon, J. N., Masri, F., Mack, A. A., Durand, N., Cameau, E., Dianat, N., Hunter, A. L., Oh, S., Schoen, B., Marsh, M., Bravery, C. A., Sumen, C., Clarke, D. M., Bharti, K., Allickson, J. G., & Lakshmipathy, U. (2024). Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group. Cytotherapy, 26(11), 1275–1284. https://doi.org/10.1016/j.jcyt.2024.05.024

MLA 9

Song, Hannah W., et al. “Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group.” Cytotherapy, vol. 26, no. 11, 2024, pp. 1275–1284. https://doi.org/10.1016/j.jcyt.2024.05.024.

Chicago

Song, Hannah W., Jennifer N. Solomon, Fernanda Masri, Amanda A. Mack, Nisha Durand, Emmanuelle Cameau, Noushin Dianat, et al. 2024. “Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group.” Cytotherapy 26 (11): 1275–1284. https://doi.org/10.1016/j.jcyt.2024.05.024.

Harvard

Song, H. W. et al. (2024) ‘Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group’, Cytotherapy, 26(11), pp. 1275–1284. doi:10.1016/j.jcyt.2024.05.024.

IEEE

H. W. Song et al., “Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group,” Cytotherapy, vol. 26, no. 11, pp. 1275–1284, 2024, doi: 10.1016/j.jcyt.2024.05.024.

BibTeX

@article{song2024bioprocessing,
  title     = {{Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group}},
  author    = {Song, Hannah W. and Solomon, Jennifer N. and Masri, Fernanda and Mack, Amanda A. and Durand, Nisha and Cameau, Emmanuelle and Dianat, Noushin and Hunter, Arwen L. and Oh, Steve and Schoen, Brianna and Marsh, Matthew and Bravery, Christopher A. and Sumen, Cenk and Clarke, Dominic M. and Bharti, Kapil and Allickson, Julie G. and Lakshmipathy, Uma},
  journal   = {Cytotherapy},
  year      = {2024},
  volume    = {26},
  number    = {11},
  pages     = {1275--1284},
  doi       = {10.1016/j.jcyt.2024.05.024},
  url       = {https://doi.org/10.1016/j.jcyt.2024.05.024}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
202555
202688

Its field-weighted citation impact is 0.46: it has been cited 0.46 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • induced pluripotent stem cells
  • cell therapy manufacturing
  • master cell bank
  • cellular reprogramming
  • intellectual property licensing
  • regulatory considerations
  • 3D cell culture
  • cryopreservation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Song, H. W., Solomon, J. N., Masri, F., Mack, A. A., Durand, N., Cameau, E., Dianat, N., Hunter, A. L., Oh, S., Schoen, B., Marsh, M., Bravery, C. A., Sumen, C., Clarke, D. M., Bharti, K., Allickson, J. G., & Lakshmipathy, U. (2024). Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group. Cytotherapy, 26(11), 1275–1284. https://doi.org/10.1016/j.jcyt.2024.05.024

How many times has this paper been cited?

14 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the PDF from this page.

Who wrote this paper?

Hannah W. Song, Jennifer N. Solomon, Fernanda Masri, Amanda A. Mack, Nisha Durand, Emmanuelle Cameau, Noushin Dianat, Arwen L. Hunter, Steve Oh, Brianna Schoen, Matthew Marsh, Christopher A. Bravery and 5 more.

What is the DOI of this paper?

10.1016/j.jcyt.2024.05.024, permanently at https://doi.org/10.1016/j.jcyt.2024.05.024. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.